Previous experiments using endothelial nitric oxide synthase (eNOS)-deficient mice showed an aggravation of MASLD pathogenesis [6,7], and it was shown that vascular endothelial dysfunction is associated with the severity of MASLD in humans [8]. The gene discussed is NOS3; the disease is metabolic dysfunction-associated steatotic liver disease.